KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Long-Term Debt Repayments (2016 - 2022)

Historic Long-Term Debt Repayments for Travere Therapeutics (TVTX) over the last 6 years, with Q1 2022 value amounting to $211.3 million.

  • Travere Therapeutics' Long-Term Debt Repayments changed N/A to $211.3 million in Q1 2022 from the same period last year, while for Dec 2022 it was $211.3 million, marking a year-over-year change of. This contributed to the annual value of $211.3 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Travere Therapeutics reported Long-Term Debt Repayments of $211.3 million as of Q1 2022.
  • In the past 5 years, Travere Therapeutics' Long-Term Debt Repayments ranged from a high of $211.3 million in Q1 2022 and a low of $500000.0 during Q2 2018